Business Context and Reporting Period
This Form 8-K was filed by Nephros, Inc. on September 11, 2018, reporting events that occurred on September 5, 2018. The filing details a material definitive agreement involving Specialty Renal Products, Inc. ("SRP"), a wholly-owned subsidiary of Nephros, Inc.
Key Financial Metrics
The filing does not provide standard financial statements (revenue, profit, cash flow, or margins) for the reporting period. The primary financial event reported is a capital raise:
- Capital Raised: Approximately $3,000,000 (gross) from the sale of 600,000 shares of SRP Series A Preferred Stock.
- Price Per Share: $5.00.
- Dividend Rate: Preferred Stock accrues dividends at $0.40 per share per annum.
- Ownership Structure Post-Closing: Nephros, Inc. retains 100% of SRP's common stock but holds a 62.5% equity interest in SRP on an as-converted to common stock basis.
Material Changes
The material change is the issuance of new equity securities by the subsidiary, SRP, which alters the capital structure and governance of the subsidiary:
- Equity Issuance: SRP issued Series A Preferred Stock to specific purchasers, including entities controlled by Nephros executives and major shareholders.
- Governance Changes: Preferred Stockholders are entitled to elect two directors of SRP, while common stockholders elect three. Preferred Stockholders also hold approval rights over fundamental corporate transactions.
- Investor Rights: New agreements grant investors registration rights, information rights, and veto powers over specific business actions (e.g., debt financing, asset sales, hiring/firing of executives) requiring consent from the lead investor, Lambda Investors LLC.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future financial performance. However, it outlines significant contractual constraints and risks:
- Operational Constraints: SRP cannot undertake certain actions, including debt financings, acquisitions, asset sales, or changes in executive leadership, without the prior consent of Lambda Investors LLC.
- Related Party Transactions: Significant portions of the investment were made by the Company's CEO (Daron Evans), CFO (Andrew Astor), and major shareholders (Lambda Investors LLC and Brian L. Pessin).
- Liquidity and Exit: The Preferred Stock is convertible into common stock at a 1-for-1 ratio, either at the holder's option or mandatorily upon a qualified IPO or majority approval.
Key Facts for Investor Verification
- Verify the exact amount of transaction-related expenses deducted from the $3,000,000 gross proceeds to determine net cash inflow.
- Confirm the specific terms of the "qualified initial public offering" that would trigger mandatory conversion of the Preferred Stock.
- Review the full text of the Investor Rights Agreement to understand the scope of Lambda Investors LLC's veto power over SRP's operations.
- Check subsequent filings (Form 10-Q) for the complete forms of the Purchase Agreement, Voting Agreement, and ROFR/Co-Sale Agreement referenced in this report.